Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides/Proteins
Therapeutic Delivery · 2023
DOI: 10.4155/tde-2023-0048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Delivery, 2023. Verfasst von Sara Salatin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Peptides, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: Food and Drug Safety Research Center, Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Biopharmaceutical products are currently well-established in nearly all branches of medicine and are believed to have great potential for the treatment of a broad spectrum of diseases. Peptide/protein drugs exhibit a predominant class of new biopharmaceuticals coming on the market in recent years. Oral delivery of peptides/proteins as a non-invasive therapeutic technique has become an appealing alternative to the parenteral route. However, the efficient oral delivery of peptides/proteins is limited because of their high molecular weight, poor stability and low biodistribution. Nanoparticles (NPs) have shown excellent results in peptide/protein delivery research. In this paper, the use of NPs as delivery systems for peptides/proteins and their ability to be efficiently delivered via the oral route have been described. Medicines made from peptides and proteins have become important for treating various diseases. One challenge is delivering them effectively through the mouth, as they can be fragile and may not distribute well in the body. Scientists have been studying the use of tiny particles called nanoparticles (NPs) to help solve these problems. In this article, we explore how NPs can enhance the delivery of peptide/protein medicines when taken orally. By using NPs as delivery platforms, these medicines can be protected and absorbed more efficiently, leading to better treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Food and Drug Safety Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Pharmaceutical and Food Control, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
- Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Sara Salatin, Soheila Montazersaheb, Afsaneh Farjami, Samin Hamidi
Förderung
- Food and Drug Safety Research Center, Tabriz University of Medical Sciences
Zitieren
APA
Salatin, S., Montazersaheb, S., Farjami, A., & Hamidi, S. (2023). Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides/Proteins. Therapeutic Delivery. https://doi.org/10.4155/tde-2023-0048
Vancouver
Salatin S, Montazersaheb S, Farjami A, Hamidi S. Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides/Proteins. Therapeutic Delivery. 2023. doi:10.4155/tde-2023-0048
BibTeX
@article{Salatin2023,
author = {Salatin, Sara and Montazersaheb, Soheila and Farjami, Afsaneh and Hamidi, Samin},
title = {Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides/Proteins},
journal = {Therapeutic Delivery},
year = {2023},
doi = {10.4155/tde-2023-0048}
}
EUVIMED